Arthritis advisory committee
This article was originally published in Pharmaceutical Approvals Monthly
Executive SummaryFDA's Arthritis Advisory Committee will meet July 29-30 to discuss subcategories of acute and chronic pain and appropriate clinical trial designs for the subcategories. The meeting will be held at the Holiday Inn in Bethesda, M
You may also be interested in...
AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.
The US agency is engaged with an ethylene oxide (EtO) sterilizer in Illinois that has temporarily closed to determine if there are any potential risks to the medical device supply chain. While the plant shut down about a month ago, regulators have only recently been made aware of the decision, which resulted from a law passed last year by the state legislature.
Pfizer's biosimilar franchise is well on its way to becoming a blockbuster business three years after the company launched its first US biosimilar.